Baxter International Inc. (BAX)
NYSE: BAX
· Real-Time Price · USD
30.16
-0.11 (-0.36%)
At close: May 23, 2025, 3:59 PM
30.20
0.15%
After-hours: May 23, 2025, 05:30 PM EDT
Baxter International Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|
| Medical Products And Therapies Revenue | 1.1B | 1.05B |
| Medical Products And Therapies Revenue Growth | +5.04% | n/a |
| Healthcare Systems and Technologies Revenue | 1.14B | 1.21B |
| Healthcare Systems and Technologies Revenue Growth | -6.27% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emea Revenue | 1.35B | 3.32B | 3.71B | 3.55B | 3.13B | 2.97B | 2.96B | 2.73B | 2.7B | 2.77B | 5.14B | 4.6B | 6.06B | 4.39B | 4.19B |
| Emea Revenue Growth | -59.33% | -10.51% | +4.42% | +13.52% | +5.42% | +0.24% | +8.42% | +1.26% | -2.78% | -45.99% | +11.73% | -24.09% | +37.89% | +4.87% | n/a |
| United States Revenue | 5.85B | 7B | 7.22B | 5.18B | 4.88B | 4.83B | 4.72B | 4.51B | 4.26B | 4B | 7.01B | 6.45B | n/a | 5.71B | 5.26B |
| United States Revenue Growth | -16.43% | -3.09% | +39.44% | +6.19% | +1.08% | +2.18% | +4.72% | +5.89% | +6.45% | -42.97% | +8.74% | n/a | n/a | +8.45% | n/a |
| Western Europe, Canada, Japan, Australia And New Zealand Revenue | 3.44B | 4.49B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Western Europe, Canada, Japan, Australia And New Zealand Revenue Growth | -23.54% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 703M | 761M | 754M | 1.02B | 729M | 977M | 744M | 964M | 995M | 912M | 941M | 970M | 1.05B | 885M | 680M | 675M | 627M | 650M | 601M | 590M | 628M | 666M | 627M | 641M | 601M | 629M | 684M | 681M | 622M | 697M | 680M | 630M | 564M | 663M | 726M | 709M | 641M | 733M | 794M | 783M | 784M |
| Selling, General, and Administrative Revenue Growth | -7.62% | +0.93% | -26.15% | +40.05% | -25.38% | +31.32% | -22.82% | -3.12% | +9.10% | -3.08% | -2.99% | -7.79% | +18.87% | +30.15% | +0.74% | +7.66% | -3.54% | +8.15% | +1.86% | -6.05% | -5.71% | +6.22% | -2.18% | +6.66% | -4.45% | -8.04% | +0.44% | +9.49% | -10.76% | +2.50% | +7.94% | +11.70% | -14.93% | -8.68% | +2.40% | +10.61% | -12.55% | -7.68% | +1.40% | -0.13% | n/a |
| Research and Development Revenue | 140M | 211M | 129M | 173M | 120M | 172M | 133M | 165M | 164M | 155M | 151M | 148M | 150M | 138M | 129M | 139M | 128M | 135M | 123M | 117M | 146M | 156M | 144M | 166M | 129M | 175M | 166M | 174M | 140M | 182M | 150M | 155M | 127M | 157M | 159M | 195M | 136M | 161M | 148M | 151M | 143M |
| Research and Development Revenue Growth | -33.65% | +63.57% | -25.43% | +44.17% | -30.23% | +29.32% | -19.39% | +0.61% | +5.81% | +2.65% | +2.03% | -1.33% | +8.70% | +6.98% | -7.19% | +8.59% | -5.19% | +9.76% | +5.13% | -19.86% | -6.41% | +8.33% | -13.25% | +28.68% | -26.29% | +5.42% | -4.60% | +24.29% | -23.08% | +21.33% | -3.23% | +22.05% | -19.11% | -1.26% | -18.46% | +43.38% | -15.53% | +8.78% | -1.99% | +5.59% | n/a |